Search Results

A retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer.

• Authors : Komazaki H; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.; Takahashi K

Subjects: Bevacizumab*/Bevacizumab*/Bevacizumab*/administration & dosage ; Bevacizumab*/Bevacizumab*/Bevacizumab*/adverse effects ; Carboplatin*/Carboplatin*/Carboplatin*/administration & dosage

• Source: Journal of gynecologic oncology [J Gynecol Oncol] 2024 Nov; Vol. 35 (6), pp. e76. Date of Electronic Publication: 2024 Mar 26.Publisher: Asian Society of Gynecologic Oncology Country of Publication: Korea (South) NLM ID: 101483150 Publication Model: Print-Electronic Cited Medium:

Record details

First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial.

• Authors : Wu X; Fudan University Shanghai Cancer Center, Shanghai, China. .; Liu J

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects

• Source: Journal of gynecologic oncology [J Gynecol Oncol] 2024 Sep; Vol. 35 (5), pp. e99. Date of Electronic Publication: 2024 Apr 22.Publisher: Asian Society of Gynecologic Oncology Country of Publication: Korea (South) NLM ID: 101483150 Publication Model: Print-Electronic Cited Medium:

Record details

Re-irradiation of anaplastic meningioma: higher dose and concomitant Bevacizumab may improve progression-free survival.

• Authors : Haisraely O; Sheba Medical Center, Tel Aviv Medical School, Tel Aviv University, Tel Aviv, Israel. .; Taliansky A

Subjects: Meningioma*/Meningioma*/Meningioma*/radiotherapy ; Meningioma*/Meningioma*/Meningioma*/pathology ; Meningioma*/Meningioma*/Meningioma*/mortality

• Source: Radiation oncology (London, England) [Radiat Oncol] 2024 Oct 02; Vol. 19 (1), pp. 135. Date of Electronic Publication: 2024 Oct 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X

Record details

Bevacizumab in frontline chemotherapy improved the survival outcome for advanced ovarian clear cell carcinoma: a multicenter retrospective analysis.

• Authors : Tate, Shinichi¹ ; Seki, Toshiyuki²; Nishikimi, Kyoko¹

• Source: Journal of Gynecologic Oncology. Sep2025, Vol. 36 Issue 5, p1-13. 13p.

Record details

Bevacizumab in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer: A Risk-Stratified Analysis.

• Authors : Öner, İrem¹ (AUTHOR) ; Karaçin, Pınar² (AUTHOR)

• Source: Pharmaceuticals (14248247). Jun2025, Vol. 18 Issue 6, p850. 17p.

Record details

Efficacy and Safety of Afatinib Plus Bevacizumab as First‐Line Treatment for Advanced NSCLC Patients With Epidermal Growth Factor Receptor (EGFR) Mutations: A Multicenter, Phase II Trial.

• Authors : Shi, Huiyang¹ (AUTHOR); Wang, Miaohan¹ (AUTHOR); Li, Junling¹ (AUTHOR)

• Source: Thoracic Cancer. Aug2025, Vol. 16 Issue 15, p1-11. 11p.

Record details

Bevacizumab combined with chemotherapy could be superior to chemotherapy alone in relapsed ovarian cancer after PARPi: evidence from a multi-center propensity score-matched analysis.

• Authors : Lin Zhong^1,2,3; Haixia Wang^1,2,3; Cuirong Lei^1,2,3

• Source: Journal of Gynecologic Oncology. May2025, Vol. 36 Issue 3, p1-13. 13p.

Record details

Comparative Study between Bevacizumab Alone and in Combination with Irinotecan in Recurrent Glioblastoma Multiforme.

• Authors : Elraey, Abdalla Gamal¹ ; Mahmoud, Hanan Shawky¹; Eldeen, Elsayed Ali Tag²

• Source: Egyptian Journal of Hospital Medicine. Jul2025, Issue 100, p2721-2726. 6p.

Record details

Extracellular Vesicles May Predict Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma.

• Authors : Egerer, Mara¹ (AUTHOR) ; Schuch, Kathrin² (AUTHOR) ; Schöler, David² (AUTHOR)

• Source: Cancers. Nov2024, Vol. 16 Issue 21, p3651. 13p.

Record details

Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients.

• Authors : Güren, Ali Kaan ; Majidova, Nargiz¹; Çakır, İclal²

• Source: Middle East Journal of Cancer. Apr2025, Vol. 16 Issue 2, p162-169. 8p.

Record details